These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

192 related articles for article (PubMed ID: 38719867)

  • 1. Transcriptomic imputation of genetic risk variants uncovers novel whole-blood biomarkers of Parkinson's disease.
    Chew G; Mai AS; Ouyang JF; Qi Y; Chao Y; Wang Q; Petretto E; Tan EK
    NPJ Parkinsons Dis; 2024 May; 10(1):99. PubMed ID: 38719867
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Neuronally Derived Extracellular Vesicle α-Synuclein as a Serum Biomarker for Individuals at Risk of Developing Parkinson Disease.
    Yan S; Jiang C; Janzen A; Barber TR; Seger A; Sommerauer M; Davis JJ; Marek K; Hu MT; Oertel WH; Tofaris GK
    JAMA Neurol; 2024 Jan; 81(1):59-68. PubMed ID: 38048087
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A radiomics approach to assess tumour-infiltrating CD8 cells and response to anti-PD-1 or anti-PD-L1 immunotherapy: an imaging biomarker, retrospective multicohort study.
    Sun R; Limkin EJ; Vakalopoulou M; Dercle L; Champiat S; Han SR; Verlingue L; Brandao D; Lancia A; Ammari S; Hollebecque A; Scoazec JY; Marabelle A; Massard C; Soria JC; Robert C; Paragios N; Deutsch E; Ferté C
    Lancet Oncol; 2018 Sep; 19(9):1180-1191. PubMed ID: 30120041
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Immune Profiling of Parkinson's Disease Revealed Its Association With a Subset of Infiltrating Cells and Signature Genes.
    Zhang X; Shao Z; Xu S; Liu Q; Liu C; Luo Y; Jin L; Li S
    Front Aging Neurosci; 2021; 13():605970. PubMed ID: 33633562
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Transcriptomic signatures for diagnosing tuberculosis in clinical practice: a prospective, multicentre cohort study.
    Hoang LT; Jain P; Pillay TD; Tolosa-Wright M; Niazi U; Takwoingi Y; Halliday A; Berrocal-Almanza LC; Deeks JJ; Beverley P; Kon OM; Lalvani A
    Lancet Infect Dis; 2021 Mar; 21(3):366-375. PubMed ID: 33508221
    [TBL] [Abstract][Full Text] [Related]  

  • 6. α-syn and SNP rs356219 as a potential biomarker in blood for Parkinson's disease in Mexican Mestizos.
    Salas-Leal AC; Salas-Pacheco SM; Gavilán-Ceniceros JAP; Castellanos-Juárez FX; Méndez-Hernández EM; La Llave-León O; Camacho-Luis A; Quiñones-Canales G; Romero-Gutiérrez E; Arias-Carrión O; Salas-Pacheco JM; Sandoval-Carrillo AA
    Neurosci Lett; 2021 May; 754():135901. PubMed ID: 33865938
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A genetic and transcriptomic assessment of the KTN1 gene in Parkinson's disease risk.
    Moore A; Crea PW; Makarious M; Bandres-Ciga S; Blauwendraat C; Diez-Fairen M
    Neurobiol Aging; 2024 Feb; 134():66-73. PubMed ID: 37992546
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A molecular signature in blood identifies early Parkinson's disease.
    Molochnikov L; Rabey JM; Dobronevsky E; Bonucelli U; Ceravolo R; Frosini D; Grünblatt E; Riederer P; Jacob C; Aharon-Peretz J; Bashenko Y; Youdim MB; Mandel SA
    Mol Neurodegener; 2012 May; 7():26. PubMed ID: 22651796
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Metagenomics of the Gut Microbiome in Parkinson's Disease: Prodromal Changes.
    Palacios N; Wilkinson J; Bjornevik K; Schwarzschild MA; McIver L; Ascherio A; Huttenhower C
    Ann Neurol; 2023 Sep; 94(3):486-501. PubMed ID: 37314861
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Integrative analysis of DNA methylation and gene expression data for the diagnosis and underlying mechanism of Parkinson's disease.
    Li D; Liang J; Guo W; Zhang Y; Wu X; Zhang W
    Front Aging Neurosci; 2022; 14():971528. PubMed ID: 36062142
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Accelerating Medicines Partnership: Parkinson's Disease. Genetic Resource.
    Iwaki H; Leonard HL; Makarious MB; Bookman M; Landin B; Vismer D; Casey B; Gibbs JR; Hernandez DG; Blauwendraat C; Vitale D; Song Y; Kumar D; Dalgard CL; Sadeghi M; Dong X; Misquitta L; Scholz SW; Scherzer CR; Nalls MA; Biswas S; Singleton AB; ; ;
    Mov Disord; 2021 Aug; 36(8):1795-1804. PubMed ID: 33960523
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Low-variance RNAs identify Parkinson's disease molecular signature in blood.
    Chikina MD; Gerald CP; Li X; Ge Y; Pincas H; Nair VD; Wong AK; Krishnan A; Troyanskaya OG; Raymond D; Saunders-Pullman R; Bressman SB; Yue Z; Sealfon SC
    Mov Disord; 2015 May; 30(6):813-21. PubMed ID: 25786808
    [TBL] [Abstract][Full Text] [Related]  

  • 13. White matter biomarker for predicting de novo Parkinson's disease using tract-based spatial statistics: a machine learning-based model.
    Zhang Q; Wang H; Shi Y; Li W
    Quant Imaging Med Surg; 2024 Apr; 14(4):3086-3106. PubMed ID: 38617147
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A computational approach to identify blood cell-expressed Parkinson's disease biomarkers that are coordinately expressed in brain tissue.
    Moni MA; Rana HK; Islam MB; Ahmed MB; Xu H; Hasan MAM; Lei Y; Quinn JMW
    Comput Biol Med; 2019 Oct; 113():103385. PubMed ID: 31437626
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Can detection and prediction models for Alzheimer's Disease be applied to Prodromal Parkinson's Disease using explainable artificial intelligence? A brief report on Digital Neuro Signatures.
    Tarnanas I; Vlamos P; Harms DR;
    Open Res Eur; 2021; 1():146. PubMed ID: 37645162
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Blood transcriptional biomarkers of acute viral infection for detection of pre-symptomatic SARS-CoV-2 infection: a nested, case-control diagnostic accuracy study.
    Gupta RK; Rosenheim J; Bell LC; Chandran A; Guerra-Assuncao JA; Pollara G; Whelan M; Artico J; Joy G; Kurdi H; Altmann DM; Boyton RJ; Maini MK; McKnight A; Lambourne J; Cutino-Moguel T; Manisty C; Treibel TA; Moon JC; Chain BM; Noursadeghi M;
    Lancet Microbe; 2021 Oct; 2(10):e508-e517. PubMed ID: 34250515
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Identification of ferroptosis related biomarkers and immune infiltration in Parkinson's disease by integrated bioinformatic analysis.
    Xing N; Dong Z; Wu Q; Zhang Y; Kan P; Han Y; Cheng X; Wang Y; Zhang B
    BMC Med Genomics; 2023 Mar; 16(1):55. PubMed ID: 36918862
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Serum miR-214 Serves as a Biomarker for Prodromal Parkinson's Disease.
    Li L; Ren J; Pan C; Li Y; Xu J; Dong H; Chen Y; Liu W
    Front Aging Neurosci; 2021; 13():700959. PubMed ID: 34776924
    [TBL] [Abstract][Full Text] [Related]  

  • 19. CSF total and oligomeric α-Synuclein along with TNF-α as risk biomarkers for Parkinson's disease: a study in LRRK2 mutation carriers.
    Majbour NK; Aasly JO; Hustad E; Thomas MA; Vaikath NN; Elkum N; van de Berg WDJ; Tokuda T; Mollenhauer B; Berendse HW; El-Agnaf OMA
    Transl Neurodegener; 2020 May; 9(1):15. PubMed ID: 32375873
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Tumor-Infiltrating PD-1
    Yang Z; Deng Y; Cheng J; Wei S; Luo H; Liu L
    Front Oncol; 2021; 11():695006. PubMed ID: 34604032
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.